Global Clinical Reference Laboratory Market Opportunities and Forecast 2020-2027
- DLR2157
- 23 September, 2020
- Pharma & Healthcare
- Pages: 120
- Global
Global Clinical Reference Laboratory Services Market, By Provider Type (Hospital-Based Market, Standalone, and Clinical Based), By Application (Laboratory Medicine, Clinical Trials, and others) opportunities and forecast 2020-2027
Market Overview
Clinical reference laboratories are generally used to support the diagnosis or analysis for the patient care and the medical research. Laboratory services are essential part of treatment, disease diagnosis, and the monitoring response to the treatment, clinical research and disease surveillance programs. The test results, thus, should be precise, consistent, and reproducible. Producing quality results includes stepwise procedure of thoughtful perfect implementation, planning, and thorough inspection of results by whole team involved.
The growing value-based outsourcing from the hospitals will boost market for the clinical reference lab services, use of advanced computerisation technology in the reference laboratories and the cost and time savings for clinics and hospitals due to rise in outsourcing by the independent laboratories are major drivers driving the market growth. However, the healthcare budgetary limits will hamper the development of the market, and also the high costs of advanced tools may lead to increase in the prices of specific tests constrain the growth of the market.
Segment Overview
The adoption of the value-based services has augmented pace as the hospitals presently have started outsourcing even all their radiology and pathology diagnostic services. One of the major reasons for growing outsourcing by the hospitals is that hospital resources are becoming constrained as result of decreasing Medicare reimbursements. Cut down in the clinical lab reimbursement under Medicare have profound impact on U.S. lab industry.
It was not restricted to direct billings, but U.S. clinical labs which depend on Medicare for almost 20% of the billings and certain groups is as high as the 80% of business that got affected. Furthermore, in continuous efforts to defend the hospital's bottom line, various hospital CEOs are considering to outsource numerous value-based services. The companies such as Inspirata and Aurora Diagnostics are increasing to offer these outsourcing contracts from the hospitals. Hence, increasing value-based outsourcing from the hospitals has improved the market for the independent reference laboratory services.
Regional Overview
The North America is projected to dominate global clinical reference laboratory market over the forecast period. The market share can be accredited to increasing number of the reference laboratories in the region and presence of prominent players in U.S, which creates lucrative prospect for the investors. The market for the clinical reference laboratories in the Europe is likely to be second-largest during forecast period.
The rising laboratory outsourcing trend in countries such as France and Germany generates more opportunities for the independent reference service providers, which will increase the revenue for the market in the region. Moreover, due to changing demographics and the aging population, requirement of the laboratory testing for investigation on cardiovascular, diabetes, and genetics is anticipated to increase in coming years. Moreover, the companies operating in the Europe are concentrating on mergers and acquisitions, this is further expected to support the market growth. Asia-Pacific is projected to be fastest-growing market owing to developing healthcare infrastructure and also the increasing disposable income.
Competitor overview
In February 2017, PeaceHealth and Quest Diagnostics augmented access to the innovative, high-value laboratory services in Pacific Northwest. Both parties formed two-part arrangement to expand the delivery of the laboratory services in U.S.
In January 2017, ARUP made the highly appreciated ISO 15189 status from College of American Pathologists (CAP), this enabled it to establish the six laboratory divisions, with about 70 individual labs into close, synchronised communication by the integrating new system.
In February 2017, Unilabs attained Alpha Medical, leading medical diagnostics corporation in Slovakia and Czech Republic, the two important Eastern European marketplaces. The acquisition aligned with the services portfolio and the company’s high-end quality standards.
Key Players
Market Segmentation
By Provider Type
Market Overview
Clinical reference laboratories are generally used to support the diagnosis or analysis for the patient care and the medical research. Laboratory services are essential part of treatment, disease diagnosis, and the monitoring response to the treatment, clinical research and disease surveillance programs. The test results, thus, should be precise, consistent, and reproducible. Producing quality results includes stepwise procedure of thoughtful perfect implementation, planning, and thorough inspection of results by whole team involved.
The growing value-based outsourcing from the hospitals will boost market for the clinical reference lab services, use of advanced computerisation technology in the reference laboratories and the cost and time savings for clinics and hospitals due to rise in outsourcing by the independent laboratories are major drivers driving the market growth. However, the healthcare budgetary limits will hamper the development of the market, and also the high costs of advanced tools may lead to increase in the prices of specific tests constrain the growth of the market.
Segment Overview
The adoption of the value-based services has augmented pace as the hospitals presently have started outsourcing even all their radiology and pathology diagnostic services. One of the major reasons for growing outsourcing by the hospitals is that hospital resources are becoming constrained as result of decreasing Medicare reimbursements. Cut down in the clinical lab reimbursement under Medicare have profound impact on U.S. lab industry.
It was not restricted to direct billings, but U.S. clinical labs which depend on Medicare for almost 20% of the billings and certain groups is as high as the 80% of business that got affected. Furthermore, in continuous efforts to defend the hospital's bottom line, various hospital CEOs are considering to outsource numerous value-based services. The companies such as Inspirata and Aurora Diagnostics are increasing to offer these outsourcing contracts from the hospitals. Hence, increasing value-based outsourcing from the hospitals has improved the market for the independent reference laboratory services.
Regional Overview
The North America is projected to dominate global clinical reference laboratory market over the forecast period. The market share can be accredited to increasing number of the reference laboratories in the region and presence of prominent players in U.S, which creates lucrative prospect for the investors. The market for the clinical reference laboratories in the Europe is likely to be second-largest during forecast period.
The rising laboratory outsourcing trend in countries such as France and Germany generates more opportunities for the independent reference service providers, which will increase the revenue for the market in the region. Moreover, due to changing demographics and the aging population, requirement of the laboratory testing for investigation on cardiovascular, diabetes, and genetics is anticipated to increase in coming years. Moreover, the companies operating in the Europe are concentrating on mergers and acquisitions, this is further expected to support the market growth. Asia-Pacific is projected to be fastest-growing market owing to developing healthcare infrastructure and also the increasing disposable income.
Competitor overview
In February 2017, PeaceHealth and Quest Diagnostics augmented access to the innovative, high-value laboratory services in Pacific Northwest. Both parties formed two-part arrangement to expand the delivery of the laboratory services in U.S.
In January 2017, ARUP made the highly appreciated ISO 15189 status from College of American Pathologists (CAP), this enabled it to establish the six laboratory divisions, with about 70 individual labs into close, synchronised communication by the integrating new system.
In February 2017, Unilabs attained Alpha Medical, leading medical diagnostics corporation in Slovakia and Czech Republic, the two important Eastern European marketplaces. The acquisition aligned with the services portfolio and the company’s high-end quality standards.
Key Players
- Sonic HealthCare Limited,
- Aurora Diagnostics,
- Unilabs,
- Quest Diagnostics,
- ARUP Laboratories,
- Clinical Reference Laboratories,
- SYNLAB International Gmbh,
- KingMed Diagnostics
Market Segmentation
By Provider Type
- Stand Alone,
- Clinical Based
- Hospital-Based Market
- Laboratory Medicine
- Clinical Trials
- Others
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- UAE
- Rest of LAMEA
1 Report Prologue 10
2 Scope of Study 12
- 2.1 Research Objective 12
- 2.2 Assumptions & Limitations 12
- 2.2.1 Assumptions 12
- 2.2.2 Limitations 12
- 2.3 Market Structure 13
- 2.4 Market Segmentation 13
- 2.4.1 By Service Providers 13
- 2.4.1.1 Introduction 13
- 2.4.1.2 Stand Alone 14
- 2.4.1.3 Hospital Based 14
- 2.4.1.4 Clinical Based 14
- 2.4.2 By Application 14
- 2.4.2.1 Introduction 14
- 2.4.2.2 Clinical Trials 14
- 2.4.2.3 Laboratory Medicine 15
- 2.4.2.4 Others 15
- 2.4.1 By Service Providers 13
3 Research Methodology 16
- 3.1 Primary Research 17
- 3.2 Secondary Research 17
4 Market Dynamics 18
- 4.1 Drivers 18
- 4.1.1 Increasing value-based outsourcing from hospitals will boost the market for clinical reference lab services 18
- 4.1.2 Application of advanced automation technology in reference laboratories 18
- 4.1.3 Cost and time savings for hospitals and clinics due to increase in outsourcing by independent laboratories 19
- 4.2 Restraints 19
- 4.2.1 Healthcare budgetary restrictions will hamper the growth of the market 19
- 4.2.2 High costs of advanced technologies may lead to an increase in the costs of specialised tests 19
- 4.3 Opportunities 20
- 4.4 Challenges 20
5 Global Clinical Reference Laboratory Market, By Service Provider 21
- 5.1 Stand Alone Market 22
- 5.2 Hospital Based Market 23
- 5.3 Clinical Based 24
6 Global Clinical Reference Laboratory Market By Applications 25
- 6.1 Clinical Trials 26
- 6.2 Laboratory Medicine 27
- 6.3 Others 28
7 Global Clinical Reference Laboratory Market By Region 29
- 7.1 North America 30
- 7.1.1 US 33
- 7.1.2 Canada 34
- 7.2 Europe 36
- 7.2.1 Introduction 36
- 7.2.2 Germany 40
- 7.2.3 France 41
- 7.2.4 UK 42
- 7.2.5 Italy 43
- 7.2.6 Spain 44
- 7.2.7 Eastern Europe 45
- 7.2.8 Rest of Europe 46
- 7.3 Asia Pacific 48
- 7.3.1 Japan 51
- 7.3.2 China 52
- 7.3.3 India 53
- 7.3.4 Rest of Asia-Pacific 54
- 7.4 Middle East & Africa 55
- 7.4.1 UAE 58
- 7.4.2 Africa 59
- 7.4.3 Rest of Middle East and Africa 60
8 Competitive Landscape 61
- 8.1 Introduction 61
- 8.1.1 Acquisitions 62
- 8.1.2 Partnership 62
- 8.1.3 Agreement 62
- 8.1.4 Other (Expansion, Launch, Recognition, Strategic Investment) 63
9 Company Profiles 64
- 9.1 Quest Diagnostics 64
- 9.1.1 Company Overview 64
- 9.1.2 Product Overview 64
- 9.1.3 Financial Overview 65
- 9.1.4 Key Developments 65
- 9.2 ARUP Laboratories 67
- 9.2.1 Company Overview 67
- 9.2.2 Product Overview 67
- 9.2.3 Financial Overview 67
- 9.2.4 Key Developments 68
- 9.3 Clinical Reference Laboratory 69
- 9.3.1 Company Overview 69
- 9.3.2 Product Overview 69
- 9.3.3 Financial Overview 69
- 9.3.4 Key Developments 70
- 9.4 Unilab 71
- 9.4.1 Company Overview 71
- 9.4.2 Product Overview 71
- 9.4.3 Financial Overview 71
- 9.4.4 Key Developments 72
- 9.5 Bioreference Laboratories 73
- 9.5.1 Company Overview 73
- 9.5.2 Product Overview 73
- 9.5.3 Financial Overview 73
- 9.5.4 Key Developments 74
- 9.6 Synlab International GmbH 75
- 9.6.1 Company Overview 75
- 9.6.2 Product Overview 75
- 9.6.3 Financial Overview 75
- 9.6.4 Key Developments 76
- 9.7 Sonic HealthCare Limited 77
- 9.7.1 Company Overview 77
- 9.7.2 Product Overview 77
- 9.7.3 Financial Overview 78
- 9.7.4 Key Developments 79
- 9.8 Aurora Diagnostics 80
- 9.8.1 Company Overview 80
- 9.8.2 Product Overview 80
- 9.8.3 Financial Services 80
- 9.8.4 Key Developments 80
- 9.9 KingMed Diagnostics 82
- 9.9.1 Company Overview 82
- 9.9.2 Product Overview 82
- 9.9.3 Financial 82
- 9.10 Laboratory Corporation of America Holdings 83
- 9.10.1 Company Overview 83
- 9.10.2 Product Overview 83
- 9.10.3 Financials 83
- 9.10.4 Key Developments 84
Report You Might be Interested
Choose License Type
- USD
- GBP
- EURO
- INR
